Saffolco Pharmachem LLP
About Saffolco Pharmachem LLP
Data last updated:
Saffolco Pharmachem LLP is a limited liability partnership (LLP) based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Chennai, under LLPIN AAR-6947.
The LLP has a total obligation of contribution of ₹34 Cr. It is led by designated partners Navin Bafna and Mahaveer Chand Bafna.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹15 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 6.7%) and EBITDA of ₹1.01 Lakh (EBITDA margin 6.7%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Saffolco Pharmachem LLP FY 2025 filings available
Saffolco Pharmachem LLP reported revenue of ₹15 Lakh (down 44% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Saffolco Pharmachem LLP
Revenue fell 44% in the latest year. EBITDA fell 88% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Saffolco Pharmachem LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ₹15 Lakh | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹1.01 Lakh | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Saffolco Pharmachem LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | 6.7% | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Saffolco Pharmachem are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Saffolco Pharmachem LLP
Saffolco Pharmachem has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navin Bafna Also directs: SMN Pharma Private Limited | Designated Partner | 22 Mar 2021 | 5 Years 6 Months | Current |
| Mahaveer Chand Bafna | Designated Partner | 23 Jan 2020 | 6 Years 8 Months | Current |
Ownership and Shareholding of Saffolco Pharmachem LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Saffolco Pharmachem LLP
Saffolco Pharmachem LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Saffolco Pharmachem LLP
Employment history and EPFO contributions of people linked to Saffolco Pharmachem.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Saffolco Pharmachem LLP
Saffolco Pharmachem LLP has 3 designated partner changes on record since 2020: 2 appointments and 1 cessation. The latest: Navin Bafna was appointed as Designated Partner on 22 Mar 2021.
Credit Ratings, Litigation & Regulatory Alerts for Saffolco Pharmachem LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Saffolco Pharmachem LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Saffolco Pharmachem LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Saffolco Pharmachem LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Saffolco Pharmachem LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saffolco Pharmachem LLP
Saffolco Pharmachem is an active limited liability partnership based in Chennai, Tamil Nadu, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2020 (6+ years old) and is registered under LLPIN AAR-6947.
Saffolco Pharmachem reported revenue of ₹15 Lakh for FY 2023 (down 44% YoY).
Saffolco Pharmachem has 2 current designated partners:
- Navin Bafna - Designated Partner
- Mahaveer Chand Bafna - Designated Partner
Saffolco Pharmachem reported a net profit of ₹1.01 Lakh (net margin 6.7%) and EBITDA of ₹1.01 Lakh (EBITDA margin 6.7%) for FY 2023, as per its filed financial statements.
The LLPIN (Limited Liability Partnership Identification Number) of Saffolco Pharmachem is AAR-6947. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Saffolco Pharmachem was incorporated on 23 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
Navin Bafna was appointed as Designated Partner on 22 Mar 2021. Sasikala Bafna ceased to be Designated Partner on 22 Mar 2021. Mahaveer Chand Bafna was appointed as Designated Partner on 23 Jan 2020.
The registered office of Saffolco Pharmachem is at 96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112.
The total obligation of contribution is ₹34 Cr.
Saffolco Pharmachem operates in the pharma industry, in the drug formulation and development segment.